Meyka Pro banner
Akerna Corp.

Akerna Corp. Fundamental Analysis (NASDAQ: KERN)

KERNNASDAQ
HealthcareMedical - Healthcare Information Services
$0.31
$0.08(36.94%)
U.S. Market opens in 3h 1m

Akerna Corp. Fundamental Analysis (NASDAQ: KERN)

Akerna Corp. (NASDAQ: KERN) shows weak financial fundamentals with a PE ratio of -0.36, profit margin of -68.25%, and ROE of -20.25%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position81.88%
PEG Ratio-0.05

Areas of Concern

ROE-20.25%
Operating Margin-80.24%
Current Ratio0.19
We analyze KERN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -70.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-70.7/100

We analyze KERN's fundamental strength across five key dimensions:

Efficiency Score

Weak

KERN struggles to generate sufficient returns from assets.

ROA > 10%
-10.08%

Valuation Score

Excellent

KERN trades at attractive valuation levels.

PE < 25
-0.36
PEG Ratio < 2
-0.05

Growth Score

Weak

KERN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

KERN shows balanced financial health with some risks.

Debt/Equity < 1
0.31
Current Ratio > 1
0.19

Profitability Score

Weak

KERN struggles to sustain strong margins.

ROE > 15%
-2024.80%
Net Margin ≥ 15%
-68.25%
Positive Free Cash Flow
No

Key Financial Metrics

Is KERN Expensive or Cheap?

P/E Ratio

KERN trades at -0.36 times earnings. This suggests potential undervaluation.

-0.36

PEG Ratio

When adjusting for growth, KERN's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Akerna Corp. at 0.03 times its book value. This may indicate undervaluation.

0.03

EV/EBITDA

Enterprise value stands at 6.14 times EBITDA. This is generally considered low.

6.14

How Well Does KERN Make Money?

Net Profit Margin

For every $100 in sales, Akerna Corp. keeps $-68.25 as profit after all expenses.

-68.25%

Operating Margin

Core operations generate -80.24 in profit for every $100 in revenue, before interest and taxes.

-80.24%

ROE

Management delivers $-20.25 in profit for every $100 of shareholder equity.

-20.25%

ROA

Akerna Corp. generates $-10.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Akerna Corp. generates limited operating cash flow of $-1.03M, signaling weaker underlying cash strength.

$-1.03M

Free Cash Flow

Akerna Corp. generates weak or negative free cash flow of $-1.04M, restricting financial flexibility.

$-1.04M

FCF Per Share

Each share generates $-2.00 in free cash annually.

$-2.00

FCF Yield

KERN converts -882.47% of its market value into free cash.

-882.47%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.001

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.20

vs 25 benchmark

ROA

Return on assets percentage

-0.10

vs 25 benchmark

ROCE

Return on capital employed

-0.13

vs 25 benchmark

How KERN Stacks Against Its Sector Peers

MetricKERN ValueSector AveragePerformance
P/E Ratio-0.3631.50 Better (Cheaper)
ROE-20.25%422.00% Weak
Net Margin-68.25%19867.00% Weak
Debt/Equity0.310.53 Strong (Low Leverage)
Current Ratio0.195.56 Weak Liquidity
ROA-10.08%1571.00% Weak

KERN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Akerna Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ